Zoetis Inc. (NYSE:ZTS) today announced that it has agreed to sell $1.850 billion of senior notes, consisting of $850.0 ...

Shares of Zoetis have been roughly average performers over the past decade. The shares seem appealingly valued at recent ...

Hypnotic Video of GIGANTIC US Aircraft Carriers in the Middle of the Sea 'Alligator Alcatraz' migrant detention camp in ...

The reality is that people and animals will always need medicine, treatments, and other products to live long and comfortable ...

Q2 2025 Management View Kristin C. Peck, CEO, reported "strong broad-based 8% organic operational revenue growth" and noted ...

Meanwhile, the company has an impeccable dividend program. The company has increased its payouts by 502% over the past decade ...

There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the ...

Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors.

Q2 2025 Earnings Conference Call August 5, 2025 8:30 AM ET. Company Participants. Kristin C. Peck - CEO & Director Steven Frank - Vice President of Investor ...

Zoetis Inc. Q2 2025 earnings highlight 8% organic revenue growth, raised guidance, and strong performance from Simparica and Key Dermatology franchises.

The global Veterinary Diagnostics Market, valued at US$3.42 billion in 2024 stood at US$3.68 billion in 2025 and is projected ...

Highlights,Zoetis exceeded earnings expectations,Reported earnings per share rose year-over-year,Showed steady growth compared to the previous quarter,Zoetis (NYSE:ZTS), a global leader in animal ...